Title |
Symptom burden, mental health and quality of life among COVID-associated mucormycosis patients: A prospective cohort study
|
Authors |
Karanvir Singh Matharoo*1, Sushma Bhatnagar2, Shoibam Jenifa3, Rohan Chauhan4 & Santenna Chenchula*5
|
Affiliation |
1Department of palliative medicine, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh, India; 2Department of Medicine, Clinical lead and senior consultant, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, India; 3Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Mangalagiri, Guntur, Andhra Pradesh, India; 4Department of Medicine, Fortis Hospital, Ludhiana, India; 5Department of Pharmacology, AIIMS Bhopal, India; *Corresponding author
|
|
Karanvir Singh Matharoo - E-mail: singhkaranvir328@gmail.com
|
Article Type |
Research Article
|
Date |
Received August 1, 2025; Revised August 31, 2025; Accepted August 31, 2025, Published August 31, 2025
|
Abstract |
COVID-associated mucormycosis (CAM) is a severe fungal infection with lasting physical and psychological effects. This prospective cohort of 53 CAM patients evaluated symptom burden, depression (PHQ-9), anxiety (GAD-7), and quality of life (WHOQOL-BREF) at baseline, 6 months and 1 year. Facial pain (89%) and headache (87%) were the most common symptoms; depression improved significantly (PHQ-9: 9.7 to 5.4; p < 0.001), while anxiety initially declined but rose again at 1 year. Quality of life improved in physical and psychological domains, whereas social and environmental aspects remained unchanged. Persistent challenges such as dysphagia (33%), voice changes (27%) and appearance concerns (27%) underscore the need for integrated long-term mental health and rehabilitation strategies in CAM care. |
Keywords |
Mucormycosis; COVID-19; depression; anxiety; mental health; quality of life
|
Citation |
Matharoo et al. Bioinformation 21(8): 2272-2277 (2025)
|
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|